Liraglutide ameliorates high glucose-induced vascular endothelial injury through TRIB3/NF-κB signaling pathway
In Vitro Cellular & Developmental Biology - Animal · 2024
DOI: 10.1007/s11626-024-00947-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vitro Cellular & Developmental Biology - Animal, 2024. Verfasst von Lili Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cadre Ward, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. Hauptthemen laut MEDLINE: Human Umbilical Vein Endothelial Cells, Signal Transduction, NF-kappa B, Glucose. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: First Clinical Hospital of Harbin Medical University Foundation for Outstanding Young Scholars, Heilongjiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
As one of the most commonly used antidiabetic medications clinically, liraglutide is involved in the protection of vascular endothelium, and whether it can relieve high glucose-induced vascular endothelial damage was unknown. This study aims to address the response of liraglutide (LIRA) on human umbilical vein endothelial cells, as well as to elucidate its possible underlying mechanism. We established a vascular endothelial cell injury model by exposing human umbilical vein endothelial cells (HUVECs) to high glucose, and used LIRA pretreatment before HG treatment to address the endothelial protective effect of LIRA. Our results suggest that LIRA prevented HG-induced HUVEC apoptosis, oxidative stress, inflammasome activation, and pyroptosis. Furthermore, silencing of tribbles homolog 3 (TRIB3) could markedly reduce HG-induced HUVEC apoptosis, ROS level, the expressions of TXNIP, cleaved caspase3, NLRP3, and caspase1, indicating TRIB3 inhibition protected HUVECs against HG-induced vascular endothelial injury. In addition, LIRA restrained NF-κB/IκB-α signaling pathway activation in HUVECs. Thus, LIRA appears to mitigate HG-induced apoptosis, oxidative stress, inflammasome activation, and pyroptosis in HUVECs via regulating the TRIB3/NF-κB/IκB-α signaling pathway. Our study provides new insight into the mechanisms underlying the protective activity of LIRA against the vascular endothelial injury in diabetic vascular complication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cadre Ward, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
- Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, 150001, China. Haoming1971@126.com.
Förderung
- First Clinical Hospital of Harbin Medical University Foundation for Outstanding Young Scholars
- Heilongjiang Provincial Natural Science Foundation of China
Zitieren
APA
Shi, L., Xu, Y., Zhao, C., Qu, G., & Hao, M. (2024). Liraglutide ameliorates high glucose-induced vascular endothelial injury through TRIB3/NF-κB signaling pathway. In Vitro Cellular & Developmental Biology - Animal. https://doi.org/10.1007/s11626-024-00947-7
Vancouver
Shi L, Xu Y, Zhao C, Qu G, Hao M. Liraglutide ameliorates high glucose-induced vascular endothelial injury through TRIB3/NF-κB signaling pathway. In Vitro Cellular & Developmental Biology - Animal. 2024. doi:10.1007/s11626-024-00947-7
BibTeX
@article{Shi2024,
author = {Shi, Lili and Xu, Yingying and Zhao, Chao and Qu, Guangjin and Hao, Ming},
title = {Liraglutide ameliorates high glucose-induced vascular endothelial injury through TRIB3/NF-κB signaling pathway},
journal = {In Vitro Cellular & Developmental Biology - Animal},
year = {2024},
doi = {10.1007/s11626-024-00947-7}
}
EUVIMED